ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 179207 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 179207; 2) Community: the network communities that were significantly associated with the response to NSC 179207; 3) Molecule: the relationships between components within communities and NSC 179207; 4) MDR: the compounds that were significantly associated with the NSC 179207.

NSC Compound Enrichment Correlation
NSC 740160 2-{4-[4-(5-morpholino-1H-benzo[d]imidazol-2-yl)phenoxy]butyl }-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione 0.045446901295916 0.010348605
NSC 740846 6-(3-fluoro-4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2H-pyran-2-one 0.045446901295916 -0.028216097
NSC 742256 8-(4-Amino-1-methylbutyl)amino-2-methyl-5,6-dihydroxyquinoline, 2.3-hydrobromide, 0.8 hydrate 0.045446901295916 0.4622547
NSC 744633 Null 0.045446901295916 0.35040963
NSC 753218 3-hydroxy-5,6-dihydro-6-imino-9-methoxyisoindolo-[2,1-a]quinoxaline 0.045446901295916 -0.17993101
NSC 754109 ethyl 8-(3-methoxybenzyl)-5,8-dihydro-4H-isoxazolo[4,5-g]indole-7-carboxylate 0.045446901295916 -0.057148297
NSC 758356 2-(1-(4-chlorophenylsulfonyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide 0.045446901295916 0.11391588
NSC 83492 Null 0.045446901295916 0.0074956892
NSC 111533 Methoxycamptothecin 0.0454469012959173 0.30109241
NSC 116878 Cardiac glycoside 0.0454469012959173 0.079507612
Total:51  Current:45    [First] [Prev] [Next] [Last]